Dr. Hua You: Development and Validation of an OS Prediction Model for HIV-Infected Liver Cancer Patients
Individuals living with HIV are at a higher risk of developing hepatocellular carcinoma (HCC) due to immune system impairment and often face poorer prognoses. At the ongoing 2024 IDWeek Conference, Dr. Hua You from the Children’s Hospital of Chongqing Medical University presented a groundbreaking study on the development of the first-ever prognostic model tailored for HIV-infected HCC patients—the HIHP model. Demonstrating remarkable performance in both internal and external validation, this model offers promising new directions for the treatment and prognosis of HIV-infected HCC patients.
